US Patent Granted for Zendia’s Rapid Test Methodology in Pathogen Detection
We are thrilled to announce the approval of Zendia GmbH’s USA Patent WO2018002327 titled “Rapid Test for Detecting Pathogens and…
Zendia Targets Market Entry with Innovative Malaria Diagnostic Solution
Zendia GmbH is aiming to enter the market bolstered by a substantial grant of 290,000 Euros from the German Federal…
ZENDIA CONDUCTS SECOND INFECTOTEST® FEASIBILITY STUDY IN KYENJOJO, UGANDA
Together with Dr Gerald Tumussime and his team in Uganda, Zendia GmbH goes back to the district of Kyenjojo to get clinical data on the real world sensitivity of InfectoTest® on a particular population
Begins Testing Phase with Lyophilized Reagents from EVIK Diagnostics
Zendia GmbH received its first batch of lyophilized reagent beads from EVIK Diagnostics, Kanata, Canada. This acquisition marks the start…
Joint Venture with Charité Universitätsmedizin & Berlin Johann Wolfgang Goethe University
InfectoTest® collaboration team received a positive answer from the ethics committee from Berlin and Frankfurt for the study protocol “Entwicklung…
Zendia Embarks on First InfectoTest® Feasibility Study in Kampala, Uganda
Zendia GmbH proudly launched its first field feasibility study, a collaboration with the medical faculty at Ugandan Christian University Under the expert guidance of Dr Gerald Tumussime and his dedicated team in Kampala, this study marks a significant milestone for InfectoTest®
Ethical Committee Endorses Zendia’s Study Protocol for Rapid Malaria Diagnostics
Zendia GmbH received feedback from the ethical committee from the Landesärztekammer Baden Württemberg regarding the submission of the Study Protocol…
Continued Commitment: BMBF Invests Further in InfectoTest®
We’re delighted to share that the commitment to innovative health solutions by the German Federal Ministry of Education and Research…
Publication alert!
Today we published our work on the interactions of the Plasmodium falciparum parasite when confronted with hemolytic agents. This was…
InfectoTest® Receives €1.1M BMBF Grant for Breakthrough Malaria Diagnostic Research
InfectoTest® team with Zendia GmbH as a project leader, are honoured to be the recipients of a generous €1.1 million…